SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MTEN - expected 1000% revenue increase in 97
MTEN 3.190+1.9%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Elio Madama who wrote (273)1/9/2000 1:25:00 PM
From: Elio Madama   of 279
 
More Info about MTEN.

FY END JUN
ISSUE DATA (12/31/99) PER SHARE DATA RATIOS
Price $ 0.03 EPS (TTM) $ -0.03 P/E (TTM) NM
52W High $ 0.23 Div. Rate $ 0.00 Yield 0.00 %
52W Low $ 0.02 Book Value $ -0.01 Price/Book NM
Shrs Out 27.41 Mil Cash $ 0.00 ROE (TTM) NM %
Float 19.20 Mil Rev (TTM) $ 0.18 ROA (TTM) -20.21 %
Mon. Vol 1.56 Mil Curr. Ratio 0.50
Beta -3.22 LT Dbt/Eqty 0.34
BRIEF: Medical Technology & Innovations is engaged in the
design, manufacture and distribution of medical screening
devices for medical professionals primarily involved in
vision screening. MTEN also distributes digital and glass
thermometers and other devices. For the 9 months ended
3/31/99, revenues rose 14% to $4.3M. Net loss fell 67% to
$295K. Revenues reflect increased demand for the MTI
PhotoScreener. Loss also benefitted from higher margins.


Copyright (c) 2000, Market Guide Inc., All rights reserved (more)

Medical Tech. & Innovat. QUARTERLY SUMMARY Page 2 of 10
HISTORICAL QUARTERLY RESULTS(Thousands of U.S. Dollars)
REVENUE 1996 1997 1998 1999
1st Qtr SEP 152 832 985 1,352
2nd Qtr DEC 119 1,015 1,425 1,820
3rd Qtr MAR 191 931 1,315 1,091
4th Qtr JUN 234 855 816
EPS (U.S. Dollars per share)
1st Qtr SEP -0.016 -0.055 -0.032 -0.003
2nd Qtr DEC -0.030 -0.071 -0.011 0.006
3rd Qtr MAR -0.030 -0.065 -0.010 -0.015
4th Qtr JUN -0.079 -0.058 -0.014

During 9/97, all Series A Preferred stock converted into
8,216,772 Common.

DIVIDENDS EMPLOYEES
Last Dividend Decl. $ NA # Employees 38
Last Div Ex-Date NA Sales/Employee (TTM) 133,658
Last Div Pay Date NA Net. Income/Empl.(TTM) NM

Copyright (c) 2000, Market Guide Inc., All rights reserved (more)

Medical Tech. & Innovat. EQUITY, OFFICERS & ADDRESS Page 5 of 10
Common Stock no Par, 3/99, 700M auth., 28,783,541 issd.,
less 1,373,531 shares in Treas. @ $310K. Insiders own 30%.
10/95, 10,263,733 shs. issd. in rev. acq. of Medical Tech.
Inc. (As of 6/98) LTD: $377K @ 12%, $1.6M @ 8% - 11.25%,
$127K @ 0% - 10%, $60K @ Prime + 7%. Conv. Pref. Series B,
$100 Par, 267 issd.; Pref. Stock $1000 par, 22.5 issd.

OFFICERS: Robert D. Brennan, Pres./COO, Jeremy P. Feakings,
Chmn./CEO, Dennis A. Surovcik, Sr. VP/CFO/Secy., John
Stefanick, Exec. VP TRANSFER AGENT: Interwest Transfer
Company. Company incorporated 1989 in FL. Direct inquiries
to: Dennis A. Surovczik, Sr. VP/CFO/Secy.
ADDRESS & PHONE NUMBERS
Medical Tech. & Innovat.
615 Centerville Road
Lancaster, PA 17601
PHONE: (717) 892-6770
FAX: (___) ___-____


Copyright (c) 2000, Market Guide Inc., All rights reserved (more)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext